Denise Braendgaard: NNHF Marks Defining Moment at ASH2025
Denise Braendgaard, General Manager of Novo Nordisk Haemophilia & Haemoglobinopathies Foundation, posted on LinkedIn:
”A defining moment at ASH2025 in Orlando
We proudly unveiled a major NNHF milestone – one that marks the start of an exciting new chapter with even greater impact.
Being there alongside some of my incredible team was a true privilege: Célia Rohrer, Llyord Mwaniki, Sara Motka. The way we unite is how we deliver on our mission: Impacting care. Together
Our event, Unveiling New Horizons, was a powerful reminder of why this journey into haemophilia – and now haemoglobinopathies – matters so deeply. The passion and commitment from our Council members, partners and experts reaffirmed that we are on the right path.
Our compact NNHF booth was small in size but big in purpose. From morning to evening, every conversation was extremely meaningful, shaping the next steps in our strategic approach across low- and middle-income countries. I loved reconnecting with long-standing partners and meeting new collaborators who share our vision for sustainable solutions.
Every interaction reminds us why partnership matters and why our mission is worth every effort. Inspired by your enthusiasm, we are committed to going above and beyond to achieve our shared goals.
Thank you to everyone joining this journey with purpose, passion, and impact: Together, we aim to reach four times more people worldwide.”
Stay updated with Hemostasis Today.
-
May 29, 2026, 04:37Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
-
May 29, 2026, 03:19Building Safer Systems for Anticoagulation Management – ISTH
-
May 29, 2026, 03:07Early Diagnosis Can Change the Lives of Women With Haemophilia – EHC
-
May 29, 2026, 02:41Ifeanyichukwu Ifechidere: The Biggest DOAC Myth in Coagulation – ‘No Monitoring Required’
-
May 29, 2026, 02:35Mariam Swidan: Why Is LDH the ‘Tattletale’ of the Lab?
-
May 29, 2026, 02:20Yuntian Wang: Multi-View Learning for Predicting Avatrombopag Response in Pediatric Immune Thrombocytopenia
-
May 29, 2026, 01:57Giuseppina Caligiuri: Pathophysiological Challenges and Emerging Therapeutic Strategies in Acute Stroke
-
May 28, 2026, 23:47Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
-
May 28, 2026, 23:47ASH Heads to ASCO26 with Career Opportunities and Global Hematology Leadership